Quantcast
Last updated on April 18, 2014 at 10:25 EDT

Latest Photosensitizer Stories

2011-11-29 08:30:00

EDMONTON, Nov. 29, 2011 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a biotechnology company developing and commercializing products for the treatment of cancer, today announced the acceptance for publication of a research paper entitled "Antitumor Efficacy of Photodynamic Therapy Using Novel Nanoformulations of Hypocrellin Photosensitizer SL052", in the Journal of Photochemistry and Photobiology. The paper highlighted the results from a research study...